Trapani A J, Balwierczak J L, Lappe R W, Stanton J L, Graybill S C, Hopkins M F, Savage P, Sperbeck D M, Jeng A Y
Pharmaceuticals Division CIBA-GEIGY Corporation, Summit, NJ 07901.
Biochem Mol Biol Int. 1993 Dec;31(5):861-7.
The IC50 values of phosphoramidon, CGS 25015, CGS 26129, thiorphan and benazeprilat for inhibition of endothelin converting enzyme partially purified from porcine aortic endothelial cells were 3.5, 18, 58, > 100 and > 100 microM, respectively. A similar rank order of potency was observed for inhibition of the proendothelin-1 (proET-1) -induced pressor response in the rat where phosphoramidon, CGS 25015, CGS 26129, thiorphan and benazeprilat at 30 mg/kg i.v. produced 65, 57, 27, 12, and 0% inhibition, respectively. A slightly different rank order of potency was obtained in the proET-induced contraction of porcine coronary arteries where IC50 values of < 10, 10-30, 10-30, 30-100 and 30-100 microM were exhibited by CGS 25015, CGS 26129, phosphoramidon, thiorphan and benazeprilat, respectively. These data indicate that the endothelin converting enzymes in the three systems studied are similar, except that phosphoramidon is a slightly more potent inhibitor in the in vitro assay and the in vivo pressor test than in the smooth muscle contraction assay.
磷酰胺脒、CGS 25015、CGS 26129、硫磷酰胺和苯那普利拉对从猪主动脉内皮细胞中部分纯化的内皮素转化酶的IC50值分别为3.5、18、58、>100和>100微摩尔。在大鼠中,对于抑制前内皮素-1(proET-1)诱导的升压反应,也观察到了类似的效价顺序,静脉注射30mg/kg的磷酰胺脒、CGS 25015、CGS 26129、硫磷酰胺和苯那普利拉分别产生65%、57%、27%、12%和0%的抑制作用。在猪冠状动脉的proET诱导收缩实验中,获得了略有不同的效价顺序,其中CGS 25015、CGS 26129、磷酰胺脒、硫磷酰胺和苯那普利拉的IC50值分别为<10、10-30、10-30、30-100和30-100微摩尔。这些数据表明,所研究的三个系统中的内皮素转化酶相似,只是磷酰胺脒在体外测定和体内升压试验中比在平滑肌收缩试验中是一种稍强效的抑制剂。